Neos Investment Management LLC Cullinan Oncology, Inc. Transaction History

Neos Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$7.13 - $9.08 $25,154 - $32,034	3,528 Added 9.01%	42,692 $321 Million
Q1 2025 May 15, 2025	BUY	$7.57 - $12.68 $81,233 - $136,069	10,731 Added 37.74%	39,164 $296 Million
Q4 2024 Feb 12, 2025	BUY	$10.77 - $17.6 $30,080 - $49,156	2,793 Added 10.89%	28,433 $346 Million
Q3 2024 Nov 13, 2024	BUY	$16.03 - $20.86 $25,920 - $33,730	1,617 Added 6.73%	25,640 $429 Million
Q2 2024 Aug 14, 2024	BUY	$15.63 - $29.35 $119,335 - $224,087	7,635 Added 46.59%	24,023 $419 Million

Q1 2024 May 13, 2024	BUY	$10.17 - $19.02 $4,901 - $9,167	482 Added 3.03%	16,388 $279 Million
Q4 2023 Feb 13, 2024	BUY	$7.89 - $10.23 $125,498 - $162,718	15,906 New	15,906 $162 Million

149

65.1M

10.7K

14.4K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $390M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Neos Investment Management LLC with notifications on news.